Skip to main content
OpenTrials
Completed

NCT Number: NCT00000318

Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1

The purpose of this study is to assess optimal dosage of buprenorphine on a thrice weekly schedule in a pilot clinical trial.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Opioid-related Disorders Chemically-Induced Disorders Mental Disorders Narcotic-Related Disorders Substance-Related Disorders

Age range

21 year–55 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

APT Residential Services Division

New Haven, Connecticut, 06519, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Please contact site for information.

Treatment and study plan

buprenorphine

Drug
  • Experimental Maintenance treatment with daily medication
  • Experimental Maintenance treatment with thrice-weekly medication

Primary outcomes

  1. Opioid and cocaine use

    Time frame: 26 weeks

  2. Social and psychological functioning

    Time frame: 26 weeks

  3. AIDS risk behavior

    Time frame: 26 weeks

Sponsors and collaborators

Lead sponsor

National Institute on Drug Abuse (NIDA)

Nih

Collaborators

  • Yale University

Registry information

Official study title

Buprenorphine Maintenance Dose Schedule and Treatment Setting: Pilot

Important dates

Study start
1994
Primary completion
2004
Study completion
2007
First posted
Sep 21, 1999
Registry last updated
Jan 12, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.